Unified Trans diagnostic Treatment

The Efficacy of Unified Trans diagnostic Treatment on Cognitive Mechanisms of Emotion Regulation, Sleep Disorder and Symptoms Remission of Premenstrual Syndrome (PMS)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201128049518N1

Enrollment

Registered

2020-12-05

Start date

2021-01-04

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: Intervention group:The first group was treated with Unified Trans diagnostic Treatment: The first group participates in Unified Trans diagnostic Treatment session for 8 weeks (One sess

Eligibility

Sex/Gender

Female

Age

17 Years to 45 Years

Inclusion criteria

Inclusion criteria: Diagnosis of premenstrual syndrome based on diagnostic and Statistical Manual of Mental Disorders (DSM) Lack of mental retardation No use of psychiatric drugs before the study

Exclusion criteria

Exclusion criteria: Dissatisfaction to participate in study Psychiatric comorbidity Drug allergy

Design outcomes

Primary

Measure	Time frame
Symptoms of Premenstrual. Timepoint: At the first of study (before the intervention), 4 and 8 week after starting psychotherapy sessions in experimental and control group premenstrual symptoms are evaluated. Method of measurement: Premenstrual Syndrome Screening (PSST).;Quality of sleep. Timepoint: At the first of study (before the intervention), 4 and 8 week after starting psychotherapy sessions in experimental and control group quality of sleep is evaluated. Method of measurement: Iowa Sleep Disturbances Inventory (ISDI).;????? ?????? ?????. Timepoint: At the first of study (before the intervention), 4 and 8 week after starting psychotherapy sessions in experimental and control group cognitive emotion regulation is evaluated. Method of measurement: Cognitive Emotion Regulation Questionnaire (CERQ).	—

Measure

Time frame

Symptoms of Premenstrual. Timepoint: At the first of study (before the intervention), 4 and 8 week after starting psychotherapy sessions in experimental and control group premenstrual symptoms are evaluated. Method of measurement: Premenstrual Syndrome Screening (PSST).;Quality of sleep. Timepoint: At the first of study (before the intervention), 4 and 8 week after starting psychotherapy sessions in experimental and control group quality of sleep is evaluated. Method of measurement: Iowa Sleep Disturbances Inventory (ISDI).;????? ?????? ?????. Timepoint: At the first of study (before the intervention), 4 and 8 week after starting psychotherapy sessions in experimental and control group cognitive emotion regulation is evaluated. Method of measurement: Cognitive Emotion Regulation Questionnaire (CERQ).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaba Hasanvandi

Khoram-Abad University of Medical Sciences

s.hasanvandi@alzahra.ac.ir+98 66 3324 2643

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026